|
LICENSE AGREEMENTS (Details Textual) (USD $)
|
12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | ||||
|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2009
Collaboration Agreement [Member]
|
Sep. 30, 2003
University Of Michigan Agreement [Member]
|
Dec. 31, 2012
University Of Michigan Agreement [Member]
|
Dec. 31, 2011
University Of Michigan Agreement [Member]
|
Dec. 31, 2003
University Of Michigan Agreement [Member]
|
Sep. 30, 2003
University Of Michigan Agreement [Member]
New Drug Application [Member]
|
Sep. 30, 2003
University Of Michigan Agreement [Member]
Maximum [Member]
|
Sep. 30, 2003
University Of Michigan Agreement [Member]
Minimum [Member]
|
|
| Agreement Expiration Period | 15 years | 2016 | ||||||
| Payment Of Licence Fee | $ 10,000 | |||||||
| Payment Of Milestone Expenses | 50,000 | |||||||
| Milestone Payment Method Description | if sales in the first 12 months are less than the amount of the milestone, then we are required to pay 50% of all sales until the milestone is satisfied. | such milestone fees may be deferred and paid within 12 months of the first commercial sale of such products | ||||||
| Sale Of Milestone Products | 400,000 | 200,000 | 100,000 | |||||
| Percentage Of Royalty Revenue | 3.00% | |||||||
| Payment Of Sublicence Fee Description | if the sublicense fee payable to the Company is between 4% and 5% of net sales, then the royalties payable to U. Mich. Shall be equal to 50% of the sublicense fee. | |||||||
| Percentage Of Reduction In Royalties Owed | 50.00% | |||||||
| Percentage Of Revenue Received In Kind | 10.00% | |||||||
| Termination Of Agreement Description | The Company may terminate the Collaboration Agreement upon breach or default by Mundipharma. Mundipharma may terminate the Collaboration Agreement upon breach or default, filing of voluntary or involuntary bankruptcy by Novelos, the termination of certain agreements with companies associated with the originators of the licensed technology, or 30-day notice for no reason. | |||||||
| Reimbursement Of Patent Maintenance Fees | $ 2,900 | $ 600 | ||||||
| Percentage Of Reduction In Market Share | 20.00% | |||||||